Loading open roles.
Loading open roles.
Our team is developing precision medicines for oncology and other therapeutic areas. We are exclusively focused on drugging transcription factors to fully unlock the therapeutic potential of this previously elusive target class. By leveraging our integrated discovery platform of capabilities, we identify novel validated ligands to the undrugged proteome. Our lead program, FX-909, is a first-in-cla
Roles are read from Flare Therapeutics’s Lever every hour and disappear here as soon as they close there.